ELIZABETH DILLON: Open Payments
NPI 1043350796 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 5 payments from 4 companies in 2025. Trend: 2023 $240 · 2024 $575 · 2025 $456
Food & beverage: $258Education: $198
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $198 |
| Stemline Therapeutics Inc. | 1 | $123 |
| Amgen Inc. | 1 | $115 |
| Adaptive Biotechnologies Corporation | 1 | $21 |
Products named: ELZONRIS, BLINCYTO, clonoSEQ.
Industry payments across FL — which companies pay providers there.
